Related Experiment Video
Updated: Jan 8, 2026

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Multimodal Data-Driven Explainable Prognostic Model for Major Adverse Cardiovascular Events Prediction in Patients
Yijun Wang1, Yaoling Wang1, Yujie Luan1
1Center of Gerontology and Geriatrics, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, No. 37, Guoxue Lane, Wuhou District, Chengdu, Sichuan, 610041, China, 86 02885422332.
This study developed a machine learning model to predict major adverse cardiovascular events (MACEs) in patients with heart failure with preserved ejection fraction (HFpEF) and unstable angina (UA). The model, implemented as a web calculator, aids in personalized prevention strategies for this high-risk group.
Area of Science:
- Cardiovascular Medicine
- Machine Learning in Healthcare
- Predictive Analytics
Background:
- Heart failure with preserved ejection fraction (HFpEF) and unstable angina (UA) often coexist, creating a high-risk cardiovascular phenotype.
- This dual condition significantly increases the incidence of major adverse cardiovascular events (MACEs).
- Identifying high-risk patients is crucial for improving outcomes and guiding clinical decisions.
Purpose of the Study:
- To develop and externally validate machine learning predictive models for MACEs in patients with coexisting UA and HFpEF.
- To create an online risk calculator for individualized prevention strategies.
- To enhance clinical decision-making for this complex patient population.
Main Methods:
- A multicenter cohort study of 4459 patients with both HFpEF and UA.
- Utilized a hybrid feature selection method (LASSO and Boruta algorithms) to identify key predictors.
- Developed and validated 33 survival models, selecting the best-performing surv.xgboost.cox model for MACE prediction.
Main Results:
- Identified 7 key predictors: diabetes mellitus, platelet count, triglyceride, systemic inflammatory response index, triglyceride-glucose-BMI, NT-proBNP, and atherogenic index of plasma.
- The surv.xgboost.cox model achieved a C-index of 0.788 in the external validation cohort, demonstrating good predictive performance.
- The model showed satisfactory calibration and clinical utility for predicting 40-month MACEs, with AUC values ranging from 0.784 to 0.81.
Conclusions:
- A surv.xgboost.cox-based predictive model for MACEs was successfully developed for patients with concurrent HFpEF and UA.
- The model was implemented as a user-friendly web-based calculator to support clinical practice.
- This tool facilitates individualized risk assessment and prevention strategies for high-risk cardiovascular patients.
Related Concept Videos
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure II: Pathophysiology
Acute Coronary Syndrome III: Diagnostic Studies
Pathophysiology of Heart Failure
Coronary Artery Disease II: Pathophysiology
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
